|
WO2020229622A1
|
|
Treatment of cutaneous lupus erythematosus
|
|
WO2020182666A1
|
|
Small molecule modulators of il-17
|
|
GB202000053D0
|
|
Crystalline bis[trans-2-[4-[2-[(1r)-1-hydroxyethyl]-6-(methylamino)imidazo[4,5-c][yridin-1-yl]cyclohexyl]acetonitrile] l-malic acid salt
|
|
TW202039473A
|
|
Small molecule modulators of il-17
|
|
GB201914498D0
|
|
An anhydrous pharmaceutical composition for maintenance treatment of psoriasis
|
|
WO2020035557A1
|
|
Novel heteroaromatic modulators of the retinoid-related orphan receptor gamma
|
|
WO2020035556A1
|
|
Novel heteroaromatic modulators of the retinoid-related orphan receptor gamma
|
|
WO2020007698A1
|
|
Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof
|
|
CN111712503A
|
|
Substituted tetrahydropyran dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
|
|
WO2019115776A1
|
|
Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
|
|
CN111712502A
|
|
Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
|
|
US2020239493A1
|
|
Substituted dihydrothienopyrimidines and their use as phosphodiesterase inhibitors
|
|
GB201814443D0
|
|
A pharmaceutical aerosol
|
|
AU2018286964A1
|
|
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
|
|
US2020009147A1
|
|
5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitors
|
|
CN110291090A
|
|
Bentyl as novel jak kinase inhibitor
|
|
CN110167944A
|
|
Substituted pyrazolo azepine * -4- ketone and its purposes as phosphodiesterase inhibitors
|
|
WO2018007198A1
|
|
Method for preparation of intermediates useful for preparation of thapsigargin and nortrilobolide
|
|
WO2017125523A1
|
|
Treatment of hand eczema
|
|
WO2017103058A1
|
|
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
|
